To confirm that UBE2N is indeed activated, AML cell lines and PD-AML samples treated with the UBE2N inhibitor (UBE2Ni) UC-764865 showed reduction of Ub-UBE2N (Figure 1, G and H). The gene discussed is UBE2N; the disease is acute myeloid leukemia.